Caring Brands expands licensing deal for Photocil and Hair Enzyme Booster to 5-year term, new territories

Caring Brands, Inc.

Revised five-year licensing agreement effective May 21, 2026, expands territories to India (existing), LATAM, Russia, Australia, and New Zealand.
SCPL's existing sublicense partners include Eris, Dr. Reddy's, Cipla, Dabur, Glenmark for Hair Enzyme Booster in multiple Asian and Middle Eastern markets.
Photocil (commercialized as Photofirst by Eris) is a patented topical for vitiligo, psoriasis, and atopic dermatitis.
Hair Enzyme Booster is a first-of-its-kind topical that increases SULT1A1 enzyme to convert Minoxidil into active form for hair growth.
CEO Glynn Wilson stated the expanded agreement reflects confidence in SCPL and aims to improve revenue stream.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.